Aptar Pharma Expands Preservative Free Technology Production in Latin America
The original release is unavailable here. Read it at the source.
Earlier from Aptargroup
- Aptar and Aceso Therapeutics Announce Collaboration to Advance Inhaled Antisense Oligonucleotide Therapy for Cystic Fibrosis
- Aptar Reports Second Quarter 2026 Results
- Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year
- Aptar Pharma Announces GMP Certification at Nanopharm, Strengthening Its Integrated Pharma Services Offering